Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice

BACKGROUND: Organ-specific metastatic context has not been incorporated into the clinical practice of guiding programmed death-(ligand) 1 [PD-(L)1] blockade, due to a lack of understanding of its predictive versus prognostic value. We aim at delineating and then incorporating both the predictive and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Si-Cong, Bai, Xue, Guo, Xue-Jun, Liu, Li, Xiao, Lu-Shan, Lin, Yan, Tan, Jia-Le, Cai, Xiao-Ting, Wen, Yu-Xiang, Ma, Hu, Fu, Q. John, Leng, Meng-Xin, Zhang, Yan-Pei, Long, Li-Li, Guo, Ze-Qin, Wu, De-Hua, Zhou, Jian-Guo, Dong, Zhong-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004108/
https://www.ncbi.nlm.nih.gov/pubmed/35410334
http://dx.doi.org/10.1186/s12916-022-02315-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004108/
https://www.ncbi.nlm.nih.gov/pubmed/35410334
http://dx.doi.org/10.1186/s12916-022-02315-2

Ejemplares similares